Notice of dividend

RNS Number : 2128U

The MedicX Fund Limited

28 July 2015

 



Press Release

For immediate release                                                                                    

28 July 2015

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Notice of dividend

The Directors have approved a quarterly dividend of 1.475p per Ordinary Share in respect of the period 1 April 2015 to 30 June 2015. The Directors expect, subject to unforeseen circumstances, to pay dividends totalling 5.9p per Ordinary Share in respect of the financial year ending 30 September 2015. The dividend will be paid on 30 September 2015 to ordinary shareholders on the register as at 14 August 2015 (the "Record Date"). The corresponding ex-dividend date will be 13 August 2015. 

The Company is offering qualifying shareholders the opportunity to take new ordinary shares in the Company, credited as fully paid, in lieu of the cash dividend to be paid on 30 September 2015, by participating in the Scrip Dividend Scheme (the "Scheme") previously put in place by the Company on 5 May 2010.

The option to participate will be available to shareholders until 9 September 2015 (the "election date").  Further information on the Scheme, together with a copy of the Scheme Document (which contains the terms and conditions of the Scheme) and relevant mandate form document, is available for inspection at the National Storage Mechanism (http://www.morningstar.co.uk/uk/nsm), or through the Scrip Dividend portal on the Company's website (http://www.medicxfund.com/scrip).

End

For further information please contact:

MedicX Fund                                                                   [phone]

David Staples, Chairman

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Buchanan                                                                        [phone]

Charles Ryland/Victoria Watkins

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 143 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the Octopus Healthcare Group. The Octopus Healthcare Group is a specialist investor, developer and manager of healthcare properties with 38 people operating across the UK.

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCGMGZNKNFGKZM